logo

IOmet Pharma Presents GLUT1 Program at Keystone Tumor Metabolism Symposium 2014

IOmet presents poster describing preclinical GLUT1 Inhibitor program at Keystone Tumor Metabolism symposium, Mar 16-20 2014, in Whistler, BC, Canada